Leonteq Securities’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
Leonteq Securities's VIR Position: Q3 2026 in Review
Leonteq Securities held its Vir Biotechnology (VIR) position steady in Q3 2026 at 20,000 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #486.
Leonteq Securities first reported a position in VIR in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.49M in Q1 2023. 263 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- Leonteq Securities held 20,000 shares of Vir Biotechnology worth $224K as of Q3 2026.
- Leonteq Securities left its Vir Biotechnology share count unchanged in Q3 2026.
- Vir Biotechnology made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #486 holding.
- Leonteq Securities first reported a position in Vir Biotechnology in Q4 2020 and has held it in 21 quarters since.
- Leonteq Securities's Vir Biotechnology position peaked at $1.49M in Q1 2023.
- 263 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.